Deion Sanders revealed the details of the mystery health issue that has been ailing him this offseason. Sanders announced during a University of Colorado news conference on Monday that he had surgery ...

Deion Sanders, the University of Colorado’s head football coach, talked about his treatment for an aggressive form of bladder cancer for the first time publicly at a news conference Monday. Sporting a ...

Colorado football coach Deion Sanders announced this week that he had his bladder removed in May after a cancerous tumor was found on the organ. Sanders was diagnosed on April 14, according to a ...

A new global survey of patient and urologist perception and experience—conducted in collaboration with leading bladder cancer professional and patient organizations—reveals the physical, mental, and ...

Bladder-intact disease-free survival was 60% 2 years posttreatment with pembrolizumab combined with gemcitabine-based chemoradiation.

Colorado head football coach Deion Sanders announced Monday he was diagnosed with bladder cancer earlier this year. Sanders held a news conference to reveal the news as Colorado embarks on fall camp ...

The coach announced he is cancer-free after having his bladder removed, and shared an amazing video of what recovery looked like for him. Now we know coach Deion Sanders was dealing with a cancerous ...

"Coach Prime" is back at full strength. Deion Sanders shared new details about the strange health issue that has plagued him during the offseason, announcing on Monday that he recently underwent ...

Extended lymphadenectomy did not improve disease-free or overall survival compared to standard lymphadenectomy in muscle-invasive bladder cancer patients. Higher perioperative morbidity and mortality ...

AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. | Following an FDA ...

The FDA will review the expansion of Anktiva plus BCG to patients with papillary-only bladder cancer, with a final decision expected by Jan.6, 2027. ・The acceptance reversed last year’s FDA refusal-to ...